Industry

Lallemand Health Solutions Acquires Dietary Pros Inc., US-Based Contract Manufacturer

The acquisition brings together two complementary forces, continue to respond to customer needs and help their growth with their respective strengths.

Expert’biome CDMO by Lallemand: leading microbiome forward

Lallemand launches Expert’Biome™ CDMO to support partners in their development of next-generation strains.

Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit

Persephone to utilize the Bacteroides technology for the rapid generation of therapeutics from its planned and ongoing biomarker studies, including the ARGONAUT study.

Probi® Sensia – New probiotic concept within cognitive health

Cognitive function, Mood, Sleep and Stress – keywords that are addressed in the new clinically supported probiotic solution, Probi® Sensia to be launched by Probi ® at SupplySide West in…

Clinical Microbiomics A/S and CosmosID Inc. Merge to Create the Global Leader in Microbiome Research Services

The purpose of the new company is to help scientists worldwide understand how the microbiome influences health and well-being– from humans and animals to plants and the environment.

Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation

VE202 is an orally administered, rationally-defined bacterial consortium candidate for the treatment of ulcerative colitis

Mood-Boosting Probiotics: the beneficial effects of Limosilactobacillus reuteri PBS072 and Bifidobacterium breve BB077

Specific probiotic strains can improve stress-related parameters in mothers after delivery.

MaaT Pharma Announces European Medicines Agency Granted MaaT033 Orphan Drug Designation Aiming to Improve Overall Survival in Patients Undergoing Hematopoietic Stem Cell transplantation

MaaT033 (capsule), which is being developed as an adjunctive and maintenance therapy to improve overall survival in allo-HSCT, has received orphan drug designation (ODD) status from the European Medicines Agency…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.